Business Standard

Cipla Share Price

Know More
BSENSE

1,506.15 16.95 (1.14%)

27-Dec-2024

1,506.60 16.05 (1.08%)

27-Dec-2024

BSE : 500087

NSE : CIPLA

Sector : Health care

ISIN Code : INE059A01026

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 27-Dec-2024 | 05:30 AM IST

Market Cap (₹ Cr.)

1,21,637

Traded Value (₹ Cr)

3.35

Volume (Shares)

22,219

Face Value (₹)

2

52-Week High (₹)

1,702.00

52-Week High Date

09-Oct-2024

52-Week Low (₹)

1,240.70

52-Week Low Date

28-Dec-2023

All Time High (₹)

1,702.00

All Time High Date

09-Oct-2024

All Time Low (₹)

0.61

All Time Low Date

07-Mar-1990

Cipla Ltd

Cipla Ltd is one of the leading pharmaceutical companies in India. The Company is in the business of manufacturing developing and marketing wide range of branded and generic formulations and Active Pharmaceutical Ingredients (APIs). Cipla's product portfolio spans complex generics as well as drugs in the respiratory anti-retroviral urology cardiology anti-infective CNS and various other key therapeutic segments. With a rich portfolio it is deepening presence in the home markets of India as well as South Africa North America and other key regulated and emerging markets. Its 47 manufacturing sites around the world produce more than 50 dosage forms and over 1500 products across wide range of th...
Read More

Cipla News

Caring for patients runs in our DNA, say Cipla's Samina Hamied, Umang Vohra_63416

7 min read

Rejuvenating Cipla: After global expansion, acquisitions on cards_63414

6 min read

Cipla looks to invest more in mRNA tech; holds discussions with firms_61928

3 min read

Cipla will use Covid-19 bulk drugs inventory when demand rises_61931

2 min read

Stocks to Watch: SBI, Cipla, Voda Idea, Gujarat Gas, Zensar, MGL, Welspun_61622

4 min read

Cipla Q4 PAT dips 12% to Rs 362 cr owing to Covid inventory impact_61494

2 min read
More

Cipla Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr.)

1,21,673

EPS - TTM (₹) [C]

57.16

P/E Ratio (X) [C]

26.36

Face Value (₹) 2
Latest Dividend (%)650.00
Latest Dividend Date 02-Aug-2024
Dividend Yield (%) 0.86
Book Value Share (₹) [C]351.18
P/B Ratio (₹) [C]4.29

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Canara Robeco Equity Hybrid Fund (IDCW-M) 112.89 7,80,000 1.02
Canara Robeco Equity Hybrid Fund - Direct (IDCW-M) 112.89 7,80,000 1.02
Canara Robeco Equity Hybrid Fund - Direct (G) 112.89 7,80,000 1.02
Canara Robeco Equity Hybrid Fund (G) 112.89 7,80,000 1.02
HDFC Hybrid Debt Fund (IDCW-M) 18.67 1,29,005 0.56
HDFC Hybrid Debt Fund (IDCW-Q) 18.67 1,29,005 0.56
HDFC Hybrid Debt Fund - Direct (IDCW-Q) 18.67 1,29,005 0.56
HDFC Hybrid Debt Fund - Direct (IDCW-M) 18.67 1,29,005 0.56
HDFC Hybrid Debt Fund (G) 18.67 1,29,005 0.56
HDFC Hybrid Debt Fund - Direct (G) 18.67 1,29,005 0.56

Load more

Research Reports

DateBrokerActionPrices(₹) Report
03-Nov-2024Edelweiss Securities Hold 1,601
28-Oct-2024Edelweiss Capital Reduce 1,507
28-Jul-2024Edelweiss Securities Hold 1,663
23-May-2024Geojit Financial Services Buy 1,685
29-Oct-2023Prabhudas Lilladher Buy 1,350

Stock Strength

Today's Low/High (₹)

1,484.00

1,512.75

Week Low/High (₹)

1,458.80

1,513.00

Month Low/High (₹)

1,423.80

1,549.00

Year Low/High (₹)

1,239.75

1,702.00

All time Low/High (₹)

0.61

1,702.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week2.32%2.35%0.840.96%
1 Month1.01%1.04%-1.91-1.90%
3 Month-9.87%-9.92%-8.03-9.04%
6 Month1.73%1.74%-0.69-0.96%
1 Year21.55%21.52%9.259.97%
3 Year62.10%61.96%37.0639.37%

Company Info

Company Information

Chairman (Non-Executive) : Y K Hamied

Vice Chairman : M K Hamied

Non-Exec. & Independent Dir. : Adil Zainulbhai

Managing Director & Global CEO : Umang Vohra

Company Sec. & Compli. Officer : Rajendra Chopra

Independent Director : Robert A Stewart

Independent Director : P R Ramesh

Independent Director : Mandar Purushottam Vaidya

Non Executive Director : Samina Hamied

Additional Director : Abhijit A Joshi

Non Executive Director : Kamil Hamied

Independent Director : Sharmila Paranjpe

Independent Director : Maya Hari

Registered Office: Cipla House Peninsula Buss Par, Ganpatrao Kadam Mg Lower Parel,Mumbai,Maharashtra-400013 Ph: 91-22-24826000

Email:cosecretary@cipla.com contactus@cipla.com

URL:http://www.cipla.com

FAQs about Cipla Ltd

1. What's the Cipla Ltd share price today?
Cipla Ltd share price was Rs 1,506.15 at close on 27th Dec 2024. Cipla Ltd share price was up by 1.14% over the previous closing price of Rs 1,489.20. Cipla Ltd share price trend:

  • Last 1 Month: Cipla Ltd share price moved up by 1.01% on BSE
  • Last 3 Months: Cipla Ltd share price moved down by 9.87% on BSE
  • Last 12 Months: Cipla Ltd share price moved up by 21.55% on BSE
  • Last 3 Years: Cipla Ltd price moved up by 62.10% on BSE


2. How can I quickly analyse the performance of the Cipla Ltd stock?
The performance of the Cipla Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 26.36
  • Price to book value ratio is 4.29
  • Dividend yield of 0.86
  • The EPS (trailing 12 months) of the Cipla Ltd stock is Rs 57.16


3. What is the market cap of Cipla Ltd?
Cipla Ltd has a market capitalisation of Rs 1,21,637 crore.


4. What is Cipla Ltd's 52-week high/low share price?
The Cipla Ltd’s 52-week high share price is Rs 1,702.00 and 52-week low share price is Rs 1,240.70.


5. Is the Cipla Ltd profitable?
On a consolidated basis, Cipla Ltd reported a profit of Rs 1,178.16 crore on a total income of Rs 5,064.17 crore for the quarter ended 2024. For the year ended Sep 2024, Cipla Ltd had posted a profit of Rs 1,306.02 crore on a total income of Rs 7,241.63 crore.


6. Which are Cipla Ltd’s peers in the Health care sector?
Cipla Ltd’s top 5 peers in the Health care sector are Sun Pharma.Inds., Divi's Lab., Cipla, Mankind Pharma, Dr Reddy's Labs, Torrent Pharma..


7. Who owns how much in Cipla Ltd?
Key changes to the Cipla Ltd shareholding are as follows:

  • Promoter holding in Cipla Ltd has gone down to 30.85 per cent as of Sep 2024 from 33.40 per cent as of Dec 2023.